GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BCL2, CA12, CA2, CA7, CACNA1C, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, ESR1, F3, FABP3, FABP4, FLT3, GPR35, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, HSPA1A, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR4, HTR7, INSR, KDR, KIT, MAOA, MET, MIF, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, SMAD3, SRC, TEK, XDH |
17.557 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, AKR1C3, ALOX15, ALPL, APP, AR, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HSPA1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, IGF1R, INSR, KDR, KIT, MMP2, MMP9, PIK3CA, PPARA, PTGES, PTGS2, RELA, SMAD3, SRC, TEK, TYR |
16.044 |
[BP] GO:0007210 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
16.044 |
[BP] GO:0098664 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
16.044 |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, AKR1C3, ALOX15, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
15.8296 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, AKR1C3, ALOX15, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
15.8091 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AKR1C3, ALPL, APP, AR, AXL, BCL2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, HTR1B, HTR5A, IGF1R, INSR, MMP2, MMP9, PIK3CA, PPARA, PTGES, PTGS2, RELA, SRC, TEK, TYR |
15.77 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, AKR1C3, ALOX15, ALPL, APP, AR, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HSPA1A, HTR1B, HTR5A, IGF1R, INSR, KDR, KIT, MMP2, PIK3CA, PPARA, PTGES, PTGS2, RELA, SMAD3, SRC, TEK, TYR |
15.6946 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
AKR1B1, AKR1C3, ALOX15, APP, AR, AXL, BCL2, CYP1B1, DRD2, EGFR, F3, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, MIF, PIK3CA, PIK3CB, PTGS2, RELA, SRC, TEK, XDH |
15.4818 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA3, AKR1B1, AKR1C3, APP, AR, BCL2, CSNK2A1, CYP1B1, DRD2, EGFR, ESR1, ESRRA, F3, FABP3, FLT3, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, IGF1R, INSR, KDR, KIT, MAP2K1, MIF, MMP12, MMP2, MMP9, NUAK1, PIM1, PTGES, PTGS1, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
15.2178 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CACNA1C, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
14.1705 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CACNA1C, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
13.963 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, EGFR, ESR1, FABP3, FABP4, FUT7, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, KIT, MET, MIF, PIK3CA, PIK3CB, PPARA, PTGES, PTGS1, PTGS2 |
13.9021 |
[BP] GO:0014070 |
response to organic cyclic compound
|
AKR1C3, ALPL, APP, AR, BCL2, CA2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ESR1, ESRRA, FLT3, HSD11B2, HTR1B, HTR5A, PTGES, PTGS2, RELA, SRC, TEK, TYR |
13.9021 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DUSP3, EGFR, ESR1, F3, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, MIF, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, RELA, SRC, TEK, XDH |
13.7612 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, AKR1C3, ALOX15, APP, AR, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, EGFR, F3, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
13.7116 |
[BP] GO:0033993 |
response to lipid
|
AKR1C3, ALPL, AR, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, HTR1B, HTR5A, PTGES, PTGS2, RELA, SRC, TYR |
12.9973 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, AKR1C3, ALPL, APP, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DRD1, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HTR1B, HTR5A, IGF1R, INSR, KIT, MMP2, PPARA, PTGS2, RELA, SMAD3, SRC, TEK |
12.6301 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, APP, AR, AXL, BCL2, CACNA1C, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESRRB, F3, FABP4, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR7, IGF1R, INSR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, PPARA, PTGS2, RELA, SMAD3, SRC, TEK, TYR |
12.3575 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, AKR1C3, ALOX15, APP, AR, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, DRD2, EGFR, ESRRA, F3, FABP4, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
12.099 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, AKR1C3, ALPL, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HTR1B, HTR5A, INSR, KIT, PPARA, PTGS2, RELA, SRC, TEK |
11.923 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AKR1C3, AR, AXL, BCL2, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, HSD17B3, INSR, KDR, KIT, MAP2K1, PIK3CA, PPARA, RELA, SMAD3, SRC, TEK, TYR |
11.5387 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA3, AKR1B1, AKR1C3, ALOX15, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ESR1, ESRRA, F3, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HSPA1A, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MIF, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGES, PTGS1, PTGS2, RELA, SMAD3, SRC, TEK, TYR |
11.3848 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AKR1C3, AR, BCL2, CSNK2A1, DRD2, EGFR, ESR1, F3, FLT3, HTR1A, HTR1B, HTR2A, HTR2B, IGF1R, INSR, KDR, KIT, MIF, MMP12, MMP2, MMP9, PIM1, PTGS2, RELA, TEK |
11.0461 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AKR1C3, ALOX15, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, KIT, MMP9, PTGES, PTGS2, RELA, SRC |
10.9069 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GPR35, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
10.6806 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ALOX15, APP, AR, BCL2, DRD1, DRD2, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MIF, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, SMAD3, SRC, TEK, XDH |
10.4598 |
[BP] GO:0048583 |
regulation of response to stimulus
|
AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, GPR35, HSPA1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
10.3785 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ALOX15, APP, AR, BCL2, DRD1, DRD2, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MIF, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, SMAD3, SRC, TEK, XDH |
10.3785 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, AKR1C3, CACNA1C, CNR1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, EGFR, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, HTR1A, HTR2A, HTR2C |
10.2023 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ALOX15, APP, AR, BCL2, DRD1, DRD2, EGFR, ESRRB, FABP3, FLT3, HTR2A, HTR2B, HTR2C, INSR, KDR, KIT, MAP2K1, MAP3K7, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, SMAD3, SRC, TEK, XDH |
9.83091 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ALOX15, APP, AR, BCL2, DRD1, DRD2, EGFR, ESRRB, FABP3, FLT3, HTR2A, HTR2B, HTR2C, INSR, KDR, KIT, MAP2K1, MAP3K7, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, SMAD3, SRC, TEK, XDH |
9.83091 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, AKR1C3, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
9.71912 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, AKR1C3, AR, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HSPA1A, HTR2B, IGF1R, KDR, KIT, MAP2K1, MET, MIF, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
9.70494 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, AKR1C3, AR, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HSPA1A, HTR2B, IGF1R, KDR, KIT, MAP2K1, MET, MIF, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
9.63845 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA3, ALOX15, APP, AR, AXL, BCL2, CA2, CA7, CACNA1C, CNR1, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, GPR35, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, KIT, MAP2K1, MET, MIF, MMP12, MMP9, PIK3CB, PPARA, PTGS2, SMAD3, SRC, TEK |
9.54944 |
[BP] GO:0007165 |
signal transduction
|
ADORA3, AKR1B1, AKR1C3, APP, AR, AXL, BCL2, CA2, CACNA1C, CNR1, CNR2, CSNK2A1, CYP1B1, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, MIF, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, RELA, SMAD3, SRC, TEK |
9.38025 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ALOX15, APP, AR, DRD2, EGFR, FLT3, HTR2A, HTR2B, HTR2C, INSR, KDR, KIT, MAP2K1, MAP3K7, MIF, PIK3CB, SRC, TEK, XDH |
9.20889 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, APP, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FUT7, HSD17B3, HSPA1A, HTR2B, HTR2C, MIF, PIK3CA, PIM1, PPARA, PTGES, PTGS1, PTGS2, TYR, XDH |
9.15516 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
8.98107 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, AKR1C3, ALOX15, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CACNA1C, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, HSD11B1, HSD17B2, HSD17B3, HTR2A, HTR2B, HTR5A, INSR, KDR, KIT, MAP2K1, MET, MIF, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, RELA, SMAD3, SRC, TEK, TYR |
8.90391 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GPR35, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
8.87885 |
[BP] GO:0009966 |
regulation of signal transduction
|
AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DUSP3, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
8.7419 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, AKR1C3, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, MIF, PIK3CA, PIK3CB, PTGES, PTGS1, PTGS2 |
8.66212 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, AKR1C3, ALOX15, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, EGFR, FABP3, FABP4, FUT7, KIT, MET, MIF, PIK3CA, PIK3CB, PPARA, PTGES, PTGS1, PTGS2 |
8.65199 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ALOX15, APP, AR, DRD2, DUSP3, EGFR, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MIF, PIK3CB, SRC, TEK, XDH |
8.5429 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
8.5429 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, AKR1C3, ALOX15, ALPL, APP, AR, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ESR1, FABP4, FLT3, HSPA1A, HTR1B, IGF1R, INSR, KDR, KIT, MMP2, MMP9, PIK3CA, PTGS2, RELA, SMAD3, SRC |
8.50855 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ALOX15, APP, AR, BCL2, DRD2, EGFR, ESRRB, FLT3, HTR2A, HTR2B, HTR2C, INSR, KDR, KIT, MAP2K1, MAP3K7, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, TEK, XDH |
8.45166 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ALOX15, APP, AR, BCL2, DRD1, DRD2, DUSP3, EGFR, ESRRB, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MIF, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, SRC, TEK, XDH |
8.39275 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, AKR1C3, AR, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HSPA1A, HTR2B, IGF1R, KDR, MAP2K1, MIF, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
8.3918 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, BCL2, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, EGFR, FABP3, HSD11B2, HTR1B, HTR2A, HTR2B, HTR2C, KDR, PTGS2, RELA, SRC |
8.38198 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AKR1C3, AXL, DRD2, EGFR, F3, INSR, KIT, MET, PIK3CA, PIK3CB, SRC, TEK, XDH |
8.36245 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, HTR2C, KIT, SRC, TEK |
8.26472 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, AKR1C3, ALOX15, ALPL, APP, AR, AXL, BCL2, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, HSD17B3, HTR5A, INSR, KDR, KIT, MAP2K1, MMP9, PIK3CA, PIM1, PPARA, PTGS2, RELA, SMAD3, SRC, TEK, TYR |
8.23956 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, AKR1C3, ALOX15, ALPL, APP, AR, AXL, BCL2, CYP1A1, CYP1B1, DRD1, EGFR, ESR1, FABP4, FLT3, HTR1B, IGF1R, INSR, KDR, KIT, MMP2, PIK3CA, PTGS2, RELA, SMAD3, SRC |
8.21037 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, MIF, PTGES, PTGS1, PTGS2 |
8.18759 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, APP, BCL2, CA12, CA2, CA7, CACNA1C, CNR1, DRD1, DRD2, EGFR, ESR1, FABP3, FABP4, GPR35, HTR2A, HTR2B, HTR2C, INSR, MET, PIK3CA, PIK3CB, SMAD3 |
8.07199 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ALOX15, APP, AR, BCL2, DRD2, EGFR, FLT3, HTR2A, HTR2B, HTR2C, INSR, KDR, KIT, MAP2K1, MAP3K7, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, TEK, XDH |
8.05904 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, EGFR, HSPA1A, HTR2B, IGF1R, KDR, KIT, MET, MIF, MMP9, PIK3CA, PIM1, PPARA, PTGS2, RELA, SMAD3, SRC, TEK |
8.02315 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, HSPA1A, HTR1A, HTR1B, HTR2B, HTR2C, IGF1R, INSR, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, RELA, SMAD3, SRC, TEK, TYR, XDH |
8.02315 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, EGFR, HSPA1A, HTR2B, IGF1R, KDR, KIT, MET, MIF, MMP9, PIK3CA, PIM1, PTGS2, RELA, SMAD3, SRC, TEK |
7.95674 |
[BP] GO:0007187 |
None
|
CNR1, CNR2, DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR4, HTR5A, HTR6, HTR7 |
7.93577 |
[BP] GO:0006690 |
icosanoid metabolic process
|
AKR1C3, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, MIF, PTGES, PTGS1, PTGS2 |
7.92927 |
[BP] GO:0032844 |
regulation of homeostatic process
|
AURKB, BCL2, CA2, CA7, CACNA1C, CNR1, DRD1, DRD2, EGFR, HTR2A, HTR2B, HTR2C, KDR, MIF, PIK3CB, PTGS2, SRC |
7.91461 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ALOX15, APP, AR, BCL2, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, TEK, XDH |
7.83615 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, HSD17B3, HTR1A, MAOA, TYR |
7.81783 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2, HSD17B3 |
7.78396 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, MAOA, NQO2, PTGS1, PTGS2, TYR, XDH |
7.73784 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ALOX15, APP, AR, BCL2, CSNK2A1, DRD2, EGFR, ESR1, F3, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, INSR, KDR, KIT, MAP2K1, MAP3K7, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
7.73784 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, AKR1C3, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
7.73319 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, DRD1, DRD2, EGFR, HSD11B2, HSPA1A, HTR1B, HTR2A, HTR2B, KIT, MMP2, PPARA, PTGS2, RELA, SMAD3, SRC, TEK, TYR |
7.6283 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AKR1C3, AXL, EGFR, F3, INSR, KIT, MET, PIK3CA, PIK3CB, SRC, TEK |
7.61924 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DRD2, EGFR, HTR2A, HTR2B, HTR2C, KDR, MAP2K1, MIF, SRC, TEK |
7.61924 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AR, AXL, BCL2, CA2, CNR1, CYP1B1, DRD2, EGFR, ESRRB, F3, HSPA1A, HTR2A, HTR2B, KDR, KIT, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PIM1, PTGS2, RELA, SMAD3, SRC, TEK |
7.57778 |
[BP] GO:0031399 |
regulation of protein modification process
|
ALOX15, APP, AR, BCL2, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MIF, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, RELA, SRC, TEK, XDH |
7.55838 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
AKR1C3, ALOX15, CYP1A1, CYP1A2, CYP1B1, PTGES, PTGS1, PTGS2 |
7.556 |
[BP] GO:0003018 |
None
|
DRD1, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2, SRC, TEK |
7.54843 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA3, APP, AR, AURKB, BCL2, CNR1, CNR2, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KIT, MAP2K1, MAP3K7, MIF, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, SMAD3, SRC, TEK, XDH |
7.42675 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, CNR1, CNR2, DRD1, DRD2, EGFR, FABP3, FLT3, HSD11B2, HTR1B, IGF1R, INSR, MMP2, PPARA, PTGS2, RELA, SRC, TEK, TYR |
7.38134 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA3, AKR1B1, AKR1C3, APP, AR, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, HSPA1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MAP2K1, MET, MIF, MMP12, MMP9, PIK3CA, PIM1, PPARA, PTGES, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
7.36326 |
[BP] GO:0010038 |
response to metal ion
|
AKR1C3, ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, KIT, MMP9, PTGES, PTGS2 |
7.36326 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, HTR2C, KIT, PPARA, PTGS2, SRC, TEK |
7.30187 |
[BP] GO:0042592 |
homeostatic process
|
AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, CACNA1C, CNR1, DRD1, DRD2, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, HTR2A, HTR2B, HTR2C, INSR, MET, PIK3CA, PIK3CB, SMAD3, SRC |
7.30187 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, PTGS2, SMAD3, SRC, TEK |
7.29054 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
AKR1C3, ALOX15, APP, AR, AURKB, BCL2, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
7.2311 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, FLT3, HSPA1A, HTR2B, HTR2C, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS2, SRC, TEK, XDH |
7.22398 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA3, APP, AR, AURKB, BCL2, CNR1, CNR2, CSNK2A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, F3, FABP4, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KIT, MAP2K1, MAP3K7, MET, MIF, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
7.17407 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, AKR1C3, ALOX15, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ESR1, FABP4, FLT3, HSPA1A, HTR1B, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MIF, MMP2, MMP9, NUAK1, PIK3CA, PTGS2, RELA, SMAD3, SRC |
7.1699 |
[BP] GO:0048545 |
response to steroid hormone
|
AKR1C3, ALPL, AR, BCL2, CA2, EGFR, FLT3, HSD11B2, HTR1B, PTGS2, RELA, SRC |
7.1647 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DRD2, DUSP3, EGFR, HTR2A, HTR2B, HTR2C, KDR, MAP2K1, MIF, SRC, TEK |
7.15263 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ALOX15, APP, AXL, BCL2, CA2, CA7, CACNA1C, CNR1, CYP19A1, DRD1, DRD2, EGFR, GPR35, HSPA1A, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, INSR, MAP2K1, MIF, MMP12, MMP9, PIK3CB, PPARA, PTGS2, SMAD3, SRC |
7.12722 |
[BP] GO:0007198 |
None
|
HTR1A, HTR1B, HTR5A, HTR7 |
7.11687 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ALOX15, APP, AR, AURKB, BCL2, CSNK2A1, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
7.11529 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, HTR1B, HTR1D, KDR, RELA, SRC |
7.11376 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA3, AKR1C3, APP, CA2, CNR1, CNR2, DRD1, DRD2, ESR1, GPR35, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, INSR, PIK3CA, PIK3CB, SRC |
7.09899 |
[BP] GO:0097756 |
None
|
HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
7.08049 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, HTR1D, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, PTGS2, SMAD3, SRC, TEK |
7.07857 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA3, APP, BCL2, CACNA1C, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, PTGS2, SMAD3, SRC, TEK |
7.05565 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA3, AKR1B1, AKR1C3, ALOX15, APP, AXL, BCL2, CA2, CA9, CNR2, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, HSD11B2, HSPA1A, HTR1A, HTR2C, KIT, MAP2K1, MAP3K7, MIF, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGES, PTGS1, PTGS2, RELA, SMAD3, SRC, TEK |
7.02718 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSD17B3, HSPA1A, HTR1A, HTR1B, HTR2B, HTR2C, IGF1R, INSR, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP2, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, RELA, SMAD3, SRC, TEK, TYR, XDH |
7.00788 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ALOX15, APP, AR, BCL2, DRD2, EGFR, ESR1, F3, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, INSR, KDR, KIT, MAP2K1, MAP3K7, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, SMAD3, SRC, TEK, XDH |
6.98932 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, CNR1, CNR2, DRD1, DRD2, EGFR, FABP3, FLT3, HSD11B2, HTR1B, IGF1R, INSR, MMP2, PPARA, PTGS2, RELA, SRC, TEK, TYR |
6.90764 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
AKR1C3, ALOX15, APP, AR, AURKB, BCL2, CSNK2A1, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
6.9047 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, PTGS2, SMAD3, SRC, TEK |
6.89581 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, BCL2, CYP1A1, EGFR, ESR1, FLT3, HTR1A, KIT, MAP2K1, MET, MIF, PIK3CB, PIM1, SRC, TEK, TYR |
6.84943 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA3, APP, AR, AXL, BCL2, CA2, CACNA1C, CNR1, CYP1B1, DRD2, EGFR, ESR1, ESRRA, ESRRB, F3, GPR35, HSPA1A, HTR2A, HTR2B, HTR2C, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PIK3CA, PIM1, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
6.84943 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MAP2K1, MET, SRC, TEK |
6.83517 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, FLT3, HSPA1A, HTR2B, HTR2C, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS2, SRC, TEK, XDH |
6.82062 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MAP2K1, MET, SRC, TEK |
6.76767 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CSNK2A1, DRD1, EGFR, FLT3, HTR2B, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, NUAK1, PIK3CA, PIM1, SRC, TEK |
6.74336 |
[BP] GO:0080134 |
regulation of response to stress
|
APP, CNR1, CNR2, CYP19A1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, HSPA1A, IGF1R, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP2, NUAK1, PPARA, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
6.74336 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, APP, CA2, CA7, CNR1, CNR2, DRD1, DRD2, EGFR, HTR1B, HTR2A, KIT, PTGS2 |
6.74336 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, APP, CA2, CA7, CNR1, CNR2, DRD1, DRD2, EGFR, HTR1B, HTR2A, KIT, PTGS2 |
6.74336 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, HTR2C, KIT, SRC, TEK |
6.6844 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ALOX15, APP, AR, AURKB, BCL2, CSNK2A1, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
6.65852 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, EGFR, HSPA1A, HTR2B, IGF1R, KDR, MIF, MMP9, PIK3CA, PIM1, PTGS2, RELA, SMAD3, SRC, TEK |
6.64724 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, DRD1, EGFR, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
6.63555 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, KIT, PIM1, SRC, TEK |
6.62744 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, AR, BCL2, CNR2, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, HTR1B, HTR2A, IGF1R, MET, MIF, MMP12, MMP9, PTGS2, RELA, SMAD3, SRC, XDH |
6.48297 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
CNR1, CNR2, CYP19A1, DRD1, DRD2, EGFR, ESR1, F3, FABP4, KDR, MAP2K1, MET, MIF, MMP12, PPARA, PTGS2, RELA, SMAD3, TEK |
6.48018 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, AR, BCL2, CNR2, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, HTR1B, HTR2A, IGF1R, MET, MIF, MMP12, MMP9, PTGS2, RELA, SMAD3, SRC, XDH |
6.46462 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
AKR1C3, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, MIF, PTGES, PTGS1, PTGS2 |
6.46462 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, DRD1, EGFR, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
6.44554 |
[BP] GO:0003013 |
None
|
DRD1, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2, SRC, TEK |
6.44179 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA3, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, HSPA1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MAP2K1, MET, MIF, MMP12, MMP9, PIK3CA, PIM1, PPARA, PTGES, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
6.4245 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, HTR2A, HTR2B, HTR2C, KDR, SRC |
6.38372 |
[BP] GO:0042310 |
None
|
HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7 |
6.32528 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, DRD1, EGFR, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
6.3001 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ALOX15, APP, AR, BCL2, DRD2, EGFR, FLT3, HTR2A, HTR2B, HTR2C, INSR, KDR, KIT, MAP2K1, MAP3K7, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, TEK, XDH |
6.28935 |
[BP] GO:0048608 |
reproductive structure development
|
AKR1C3, AR, AXL, BCL2, CYP19A1, ESR1, HSD17B2, HSD17B3, INSR, KIT, MAP2K1, SRC |
6.2796 |
[BP] GO:0048870 |
cell motility
|
AXL, CNR2, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, KIT, MAP2K1, MIF, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC, TEK |
6.17357 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
DUSP3, EGFR, FLT3, HTR2A, HTR2B, IGF1R, INSR, KIT, MAP2K1, MAP3K7, MIF, PIK3CB, SRC |
6.16876 |
[BP] GO:0097746 |
None
|
DRD1, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
6.13924 |
[BP] GO:0035296 |
None
|
DRD1, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
6.13924 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AKR1C3, APP, AXL, BCL2, CYP1B1, EGFR, HSPA1A, MMP9, PTGS1, PTGS2, RELA, SRC |
6.13508 |
[BP] GO:0040011 |
locomotion
|
AXL, CNR2, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, KIT, MAP2K1, MET, MIF, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC, TEK |
6.13508 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, DRD1, EGFR, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
6.12103 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
6.09048 |
[BP] GO:0016477 |
cell migration
|
AXL, CNR2, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, KIT, MIF, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC, TEK |
6.09048 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
CA2, CA7, CNR1, CNR2, DRD2, HTR1B |
6.09048 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, AKR1C3, ALPL, APP, AR, AXL, BCL2, CNR1, CYP19A1, CYP1A1, DRD1, EGFR, ESR1, ESRRB, HSD11B2, HSD17B2, HSD17B3, INSR, KIT, MAP2K1, MMP2, MMP9, PTGS2, SRC |
6.0827 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, MAP3K7, PIM1, PPARA, RELA, SRC |
6.01996 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ALOX15, AR, BCL2, CNR1, CNR2, CYP19A1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PPARA, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
5.9974 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CSNK2A1, DRD1, EGFR, FLT3, HTR2B, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK |
5.98365 |
[BP] GO:0050801 |
ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, EGFR, ESR1, FABP3, GPR35, HTR2A, HTR2B, HTR2C, PIK3CB, SMAD3 |
5.96131 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
CNR1, DRD1, DRD2, EGFR, HTR1B, HTR2A, PTGS2 |
5.93824 |
[BP] GO:0050880 |
None
|
DRD1, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
5.93404 |
[BP] GO:0044093 |
positive regulation of molecular function
|
APP, AR, AURKB, BCL2, DRD2, EGFR, ESR1, ESR2, F3, FLT3, HSPA1A, HTR2A, HTR2B, INSR, KIT, MAP2K1, MAP3K7, MET, MIF, MMP9, PIK3CA, PIK3CB, RELA, SMAD3, SRC, TEK, XDH |
5.91717 |
[BP] GO:0003008 |
None
|
AKR1B1, AKR1C3, APP, BCL2, CNR1, CNR2, CYP1B1, DRD1, DRD2, EGFR, HSD11B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, INSR, KIT, PIK3CA, PTGS2, SRC, TEK, TYR |
5.91717 |
[BP] GO:0035150 |
None
|
DRD1, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
5.91222 |
[BP] GO:0006631 |
fatty acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, MIF, PPARA, PTGES, PTGS1, PTGS2 |
5.89397 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ALOX15, APP, AR, BCL2, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MIF, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
5.89397 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
AKR1C3, CNR1, CYP1A1, FABP3, FLT3, HTR2A, HTR2B, HTR2C, KIT, PPARA, PTGS2, SRC, TEK |
5.88539 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, AKR1C3, APP, AR, DRD1, EGFR, ESR1, FLT3, HTR1B, IGF1R, INSR, KIT, MMP2, PTGS2, RELA, SMAD3, SRC |
5.84963 |
[BP] GO:0007154 |
None
|
AKR1C3, AR, AXL, BCL2, CACNA1C, CNR1, DRD1, DRD2, ESR2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, PTGS2, TEK |
5.84688 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
AKR1C3, ALPL, AR, AXL, BCL2, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, HSD17B3, INSR, KIT, MAP2K1, PTGS2, SRC |
5.82621 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, HSPA1A, HTR1A, HTR1B, HTR2B, HTR2C, IGF1R, INSR, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, RELA, SMAD3, SRC, TEK, TYR, XDH |
5.81206 |
[BP] GO:0035556 |
intracellular signal transduction
|
AKR1B1, AXL, BCL2, CACNA1C, CYP1B1, DRD1, DRD2, EGFR, HTR2A, HTR2B, HTR5A, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, MIF, NUAK1, PIK3CA, PIK3CB, RELA, SRC, TEK |
5.79574 |
[BP] GO:0048732 |
gland development
|
AR, BCL2, CSNK2A1, CYP19A1, EGFR, INSR, MAP2K1, PIK3CA, RELA, SMAD3, TYR |
5.78916 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX15, ALOX5, MIF, PTGES, PTGS1, PTGS2 |
5.73776 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, CNR2, DRD1, DRD2, HTR1B, HTR2A, PTGS2 |
5.7244 |
[BP] GO:0050795 |
None
|
CNR1, DRD2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B |
5.7244 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
AKR1C3, ALOX15, CYP1A1, CYP1A2, CYP1B1, PTGES, PTGS1, PTGS2 |
5.67917 |
[BP] GO:0007610 |
None
|
APP, BCL2, CNR1, DRD1, DRD2, EGFR, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, INSR, KIT, PPARA, PTGS2 |
5.60187 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA3, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BCL2, CA12, CA2, CA7, CA9, CACNA1C, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GPR35, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
5.4494 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, EGFR, ESR1, GPR35, HTR2A, HTR2B, HTR2C, PIK3CB, SMAD3 |
5.43344 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AKR1C3, AXL, CYP1B1, EGFR, MMP9, RELA, SRC |
5.42591 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
EGFR, FLT3, HTR2A, HTR2B, INSR, KIT, MAP2K1, MAP3K7, MIF, PIK3CB, SRC |
5.42425 |
[BP] GO:0031960 |
response to corticosteroid
|
AKR1C3, ALPL, BCL2, EGFR, FLT3, HSD11B2, HTR1B, PTGS2, SRC |
5.38032 |
[BP] GO:0007188 |
None
|
CNR1, DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR5A, HTR7 |
5.35927 |
[BP] GO:0051094 |
positive regulation of developmental process
|
APP, AR, AXL, BCL2, CA2, CNR1, CYP1B1, DRD2, ESRRB, F3, HTR2A, HTR2C, INSR, KDR, KIT, MAP2K1, PIM1, PTGS2, RELA, SMAD3, SRC, TEK |
5.3431 |
[BP] GO:0015701 |
bicarbonate transport
|
CA12, CA14, CA2, CA4, CA7, CA9 |
5.29816 |
[BP] GO:0043549 |
regulation of kinase activity
|
APP, DRD2, DUSP3, EGFR, FABP4, FLT3, HTR2A, HTR2B, IGF1R, INSR, KIT, MAP2K1, MAP3K7, MIF, PIK3CA, PIK3CB, SRC, TEK |
5.28143 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B, HTR2C |
5.28143 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AKR1C3, APP, AR, AXL, CYP1B1, DRD1, EGFR, ESR1, IGF1R, INSR, MMP2, MMP9, PIK3CA, PTGS2, RELA, SRC |
5.2793 |
[BP] GO:0007193 |
None
|
DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR5A, HTR7 |
5.23853 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, APP, AR, AURKB, AXL, BCL2, CNR1, DRD2, ESR1, HSPA1A, IGF1R, INSR, KDR, KIT, MAP2K1, MET, MMP1, MMP9, SMAD3, SRC, TEK |
5.23395 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
APP, BCL2, CACNA1C, DRD1, DRD2, EGFR, ESR1, GPR35, HTR2A, HTR2B, HTR2C, PIK3CB, SMAD3 |
5.23395 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, SRC, TEK |
5.20991 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MAP3K7, MET, MMP2, MMP9, PIK3CA, PIK3CB, SMAD3, SRC, TEK |
5.18298 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, HTR1A, MAOA, TYR |
5.17117 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
AKR1C3, ALPL, APP, AR, CYP1A1, CYP1B1, DRD1, EGFR, ESR1, FLT3, PTGS2, SRC |
5.1583 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, HSPA1A, HTR2B, HTR2C, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, RELA, SMAD3, SRC, TEK, TYR, XDH |
5.11044 |
[BP] GO:0006939 |
None
|
DRD1, DRD2, HTR1D, HTR2A, HTR2B, HTR7 |
5.09761 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ALOX15, APP, AR, BCL2, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MIF, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
5.08955 |
[BP] GO:0031347 |
regulation of defense response
|
CNR1, CNR2, CYP19A1, DRD2, EGFR, ESR1, FABP4, HSPA1A, MAP3K7, MMP12, MMP2, PPARA, PTGS2, RELA, SMAD3, SRC, TEK |
5.03663 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
APP, DRD2, DUSP3, EGFR, FABP4, FLT3, HTR2A, HTR2B, IGF1R, INSR, KIT, MAP2K1, MAP3K7, MIF, PIK3CA, PIK3CB, SRC |
5.02275 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AKR1C3, AXL, BCL2, CYP1B1, EGFR, MMP9, RELA, SRC |
5.00034 |
[BP] GO:0043269 |
regulation of ion transport
|
APP, BCL2, CA2, CA7, CACNA1C, CNR1, DRD1, DRD2, GPR35, HTR1A, HTR1B, HTR2A, MIF, MMP9, PTGS2 |
4.99162 |
[BP] GO:0006693 |
None
|
AKR1C3, MIF, PTGES, PTGS1, PTGS2 |
4.99162 |
[BP] GO:0006692 |
None
|
AKR1C3, MIF, PTGES, PTGS1, PTGS2 |
4.99162 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FLT3, FUT7, HSPA1A, HTR1A, HTR2B, HTR2C, IGF1R, INSR, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIM1, PPARA, PTGS2, RELA, SMAD3, SRC, TEK, TYR, XDH |
4.99162 |
[BP] GO:0099536 |
None
|
CNR1, DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
4.94545 |
[BP] GO:0099537 |
None
|
CNR1, DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
4.94545 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, HSPA1A, MAOA |
4.94545 |
[BP] GO:0019371 |
None
|
AKR1C3, PTGES, PTGS1, PTGS2 |
4.92434 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, DRD2, EGFR, PPARA, SMAD3 |
4.91659 |
[BP] GO:0051338 |
regulation of transferase activity
|
APP, AURKB, DRD2, DUSP3, EGFR, FABP4, FLT3, HTR2A, HTR2B, IGF1R, INSR, KIT, MAP2K1, MAP3K7, MIF, PIK3CA, PIK3CB, SRC, TEK |
4.88852 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, AKR1C3, CSNK2A1, DRD1, DRD2, HTR1A, MAOA |
4.86021 |
[BP] GO:0055080 |
cation homeostasis
|
APP, BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, EGFR, ESR1, GPR35, HTR2A, HTR2B, HTR2C, PIK3CB, SMAD3 |
4.83329 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
APP, BCL2, CACNA1C, DRD1, DRD2, ESR1, GPR35, HTR2A, HTR2B, HTR2C, PIK3CB, SMAD3 |
4.81968 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
DRD2, EGFR, FLT3, HTR2A, HTR2B, INSR, KIT, MAP2K1, MAP3K7, MIF, PIK3CA, PIK3CB, SRC, TEK |
4.76775 |
[BP] GO:0006636 |
unsaturated fatty acid biosynthetic process
|
ALOX15, MIF, PTGES, PTGS1, PTGS2 |
4.7672 |
[BP] GO:0006928 |
movement of cell or subcellular component
|
APP, AXL, CNR2, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, KIT, MAP2K1, MIF, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, TEK |
4.73207 |
[BP] GO:0050793 |
regulation of developmental process
|
APP, AR, AXL, BCL2, CA2, CNR1, CYP1B1, DRD2, EGFR, ESR1, ESRRA, ESRRB, F3, HTR2A, HTR2C, INSR, KDR, KIT, MAP2K1, MIF, NUAK1, PIK3CA, PIM1, PPARA, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
4.70612 |
[BP] GO:0055074 |
calcium ion homeostasis
|
APP, BCL2, CACNA1C, DRD1, DRD2, ESR1, GPR35, HTR2A, HTR2B, HTR2C, PIK3CB, SMAD3 |
4.68693 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, AKR1C3, EGFR, FABP3, HSD17B2, KDR, MMP2, PTGES, PTGS2, RELA, SRC |
4.65299 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, EGFR, HTR1A, INSR, MAOA, PTGS2, SMAD3 |
4.64486 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AKR1C3, AXL, CYP1B1, EGFR, HSPA1A, MMP9, RELA, SRC |
4.64486 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA3, AKR1C3, ALOX15, APP, AR, AURKB, BCL2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HSPA1A, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
4.63986 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
APP, BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, ESR1, GPR35, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB, SMAD3 |
4.63986 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
APP, BCL2, CACNA1C, DRD1, DRD2, ESR1, GPR35, HTR2A, HTR2B, HTR2C, PIK3CB, SMAD3 |
4.63968 |
[BP] GO:0043271 |
negative regulation of ion transport
|
BCL2, CNR1, DRD2, GPR35, HTR1B, HTR2A, MMP9, PTGS2 |
4.63937 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB |
4.63621 |
[BP] GO:0002682 |
regulation of immune system process
|
ALOX15, APP, AXL, BCL2, CA2, CNR1, CNR2, CYP19A1, DRD2, DUSP3, ESR1, ESRRA, HSPA1A, KIT, MAP3K7, MIF, MMP12, MMP2, PIK3CA, PIK3CB, RELA, SMAD3, SRC |
4.63332 |
[BP] GO:0001516 |
None
|
MIF, PTGES, PTGS1, PTGS2 |
4.63332 |
[BP] GO:0046457 |
None
|
MIF, PTGES, PTGS1, PTGS2 |
4.63332 |
[BP] GO:0030003 |
cellular cation homeostasis
|
APP, BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, ESR1, GPR35, HTR2A, HTR2B, HTR2C, PIK3CB, SMAD3 |
4.61962 |
[BP] GO:0001666 |
response to hypoxia
|
BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
4.60198 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
AKR1C3, APP, AR, AURKB, BCL2, CNR1, CNR2, CSNK2A1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HSPA1A, HTR1B, HTR1E, HTR2B, IGF1R, KDR, MAP2K1, MET, MIF, MMP12, MMP9, PIK3CA, PPARA, PTGS2, RELA, SMAD3, SRC, XDH |
4.59124 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
APP, AURKB, BCL2, DRD2, EGFR, ESR1, F3, FLT3, HSPA1A, HTR2A, HTR2B, INSR, KIT, MAP2K1, MAP3K7, MIF, PIK3CA, PIK3CB, SMAD3, SRC, TEK, XDH |
4.56255 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.53133 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AR, AURKB, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, MAP2K1, MET, MMP12, PPARA, PTGS2, RELA, SMAD3, SRC |
4.5278 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
EGFR, ESR1, HTR2A, HTR2B, KIT |
4.51156 |
[BP] GO:0006873 |
cellular ion homeostasis
|
APP, BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, ESR1, GPR35, HTR2A, HTR2B, HTR2C, PIK3CB, SMAD3 |
4.50299 |
[BP] GO:0071248 |
cellular response to metal ion
|
AKR1C3, ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
4.50019 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
4.49447 |
[BP] GO:0008217 |
None
|
AR, CNR1, DRD2, HSD11B2, PPARA, PTGS1, PTGS2, SMAD3 |
4.48243 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
DUSP3, EGFR, FLT3, HTR2A, HTR2B, IGF1R, INSR, KIT, MAP2K1, MAP3K7, MIF, PIK3CB, SRC |
4.42363 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA3, AKR1C3, ALOX15, APP, AR, AURKB, BCL2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HSPA1A, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
4.42363 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
AURKB, DRD2, EGFR, FLT3, HTR2A, HTR2B, INSR, KIT, MAP2K1, MAP3K7, MIF, PIK3CA, PIK3CB, SRC, TEK |
4.41386 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, EGFR, HTR6 |
4.39536 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA3, AKR1C3, ALOX15, APP, AR, AURKB, BCL2, CA9, CNR1, CSNK2A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HSPA1A, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
4.36183 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, PTGES, PTGS2, RELA, SRC |
4.36183 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, HSD11B2, IGF1R, INSR, PPARA, PTGS2, RELA, SRC, TEK |
4.35777 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR |
4.34082 |
[BP] GO:1900274 |
regulation of phospholipase C activity
|
EGFR, ESR1, HTR2A, HTR2B, KIT |
4.34082 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA12, CA2, CA4, CA7, CA9 |
4.34082 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
EGFR, FLT3, HTR2A, HTR2B, INSR, KIT, MAP2K1, MAP3K7, MIF, PIK3CB, SRC |
4.33916 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
DRD2, EGFR, FLT3, HTR2A, HTR2B, INSR, KIT, MAP2K1, MAP3K7, MIF, PIK3CA, PIK3CB, SRC |
4.33277 |
[BP] GO:0023052 |
None
|
AR, CACNA1C, CNR1, DRD1, DRD2, ESR2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, TEK |
4.32576 |
[BP] GO:0009991 |
response to extracellular stimulus
|
AKR1C3, ALPL, AXL, BCL2, CNR1, CYP1A1, EGFR, HSD11B2, PTGS2, RELA, SRC, TYR |
4.31356 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, HTR2A, INSR, MET, SMAD3, SRC |
4.31353 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, DUSP3, ESR1, HSPA1A, IGF1R, MET, MIF, MMP9, PTGS2, RELA, SRC, XDH |
4.31012 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, EGFR, HTR1B, KDR, PTGS2, RELA, SRC |
4.30693 |
[BP] GO:0006954 |
inflammatory response
|
ADORA3, ALOX15, AXL, CNR2, KIT, MIF, PIK3CA, PIK3CB, PTGES, PTGS1, PTGS2, RELA |
4.28901 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B, HTR2C |
4.28465 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, EGFR, ESR1, HTR7, KIT, PPARA, SRC |
4.28465 |
[BP] GO:0009416 |
response to light stimulus
|
APP, AURKB, BCL2, DRD1, DRD2, EGFR, KIT, PTGS2, RELA, TYR |
4.27216 |
[BP] GO:0044283 |
None
|
AKR1B1, AKR1C3, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP3A4, HSD17B3, MIF, PTGES, PTGS1, PTGS2 |
4.25279 |
[BP] GO:0009894 |
regulation of catabolic process
|
BCL2, CNR1, CSNK2A1, EGFR, ESRRB, HSPA1A, HTR2A, HTR2B, INSR, KDR, MAP3K7, MET, PIK3CA, PIK3CB, PPARA, RELA, SMAD3 |
4.24143 |
[BP] GO:0070482 |
response to oxygen levels
|
BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
4.19555 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
AKR1C3, CYP19A1, HSD17B3 |
4.18893 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B, HTR2C |
4.18893 |
[BP] GO:0007268 |
None
|
DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
4.18754 |
[BP] GO:0098916 |
None
|
DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
4.18754 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, EGFR, MMP2, MMP9, TEK |
4.18464 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, CNR1, DRD1, DRD2, EGFR, PIK3CB, PTGS2 |
4.1719 |
[BP] GO:0007267 |
None
|
AR, CNR1, DRD1, DRD2, ESR2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, TEK |
4.16477 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, PTGES, PTGS2, RELA, SRC |
4.13945 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AR, AURKB, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2A, HTR2B, HTR2C, IGF1R, INSR, MAP2K1, MET, MMP12, PPARA, PTGS2, RELA, SMAD3, SRC |
4.13277 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
AKR1C3, BCL2, CYP1B1, EGFR, INSR, PTGS2, SMAD3, XDH |
4.12147 |
[BP] GO:0007568 |
aging
|
AURKB, BCL2, CNR1, CYP1A1, HTR2A, MAP2K1, MIF, PTGS2, RELA |
4.09969 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR1D, HTR2B |
4.08661 |
[BP] GO:0055065 |
metal ion homeostasis
|
APP, BCL2, CACNA1C, DRD1, DRD2, EGFR, ESR1, GPR35, HTR2A, HTR2B, HTR2C, PIK3CB, SMAD3 |
4.08624 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CNR1, CNR2, CSNK2A1, CYP1B1, DRD2, DUSP3, ESR1, FABP4, GPR35, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, SRC |
4.08624 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
AKR1C3, ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
4.07187 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, HTR1B, MMP2, MMP9, PTGS2 |
4.04784 |
[BP] GO:0007611 |
None
|
APP, CNR1, DRD1, DRD2, EGFR, HTR2A, INSR, KIT, PTGS2 |
4.04716 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
APP, CA2, CA7, DRD1, DRD2, EGFR, PTGS2 |
4.02862 |
[BP] GO:0051090 |
regulation of DNA binding transcription factor activity
|
ADORA3, APP, AR, CYP1B1, ESR1, ESR2, HSPA1A, KIT, MAP3K7, PIM1, RELA |
3.96447 |
[BP] GO:0050727 |
regulation of inflammatory response
|
CNR1, CNR2, CYP19A1, EGFR, ESR1, FABP4, PPARA, PTGS2, RELA, SMAD3, TEK |
3.96447 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR |
3.94017 |
[BP] GO:1901570 |
None
|
ALOX15, ALOX5, MIF, PTGES, PTGS1, PTGS2 |
3.92645 |
[BP] GO:0032787 |
None
|
AKR1C3, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, MIF, PPARA, PTGES, PTGS1, PTGS2 |
3.89952 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, DRD1, EGFR, HTR1B, IGF1R, INSR, MMP2, PTGS2, RELA, SRC |
3.89952 |
[BP] GO:0001819 |
positive regulation of cytokine production
|
CYP1B1, DRD2, HSPA1A, HTR2B, MAP3K7, MIF, MMP12, PTGS2, RELA, SMAD3, SRC |
3.89952 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, EGFR, PTGS2, RELA, TYR |
3.87084 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
APP, BCL2, CACNA1C, DRD1, DRD2, ESR1, GPR35, HTR2A, HTR2B, HTR2C, PIK3CB, SMAD3 |
3.84794 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
3.83752 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DRD1, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, SRC, TEK |
3.83529 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
3.81727 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, EGFR, FABP3, FABP4, KIT, MET, PIK3CA, PIK3CB |
3.81264 |
[BP] GO:0031667 |
response to nutrient levels
|
AKR1C3, ALPL, BCL2, CNR1, CYP1A1, EGFR, HSD11B2, PTGS2, RELA, SRC, TYR |
3.80355 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, CACNA1C, CNR1, CYP19A1, DRD2, EGFR, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, MIF, MMP12, SRC |
3.76947 |
[BP] GO:0019725 |
cellular homeostasis
|
APP, BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, ESR1, GPR35, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB, SMAD3 |
3.74924 |
[BP] GO:0010518 |
positive regulation of phospholipase activity
|
EGFR, ESR1, HTR2A, HTR2B, KIT |
3.73224 |
[BP] GO:0007200 |
None
|
DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C |
3.73224 |
[BP] GO:0007584 |
response to nutrient
|
AKR1C3, ALPL, CNR1, CYP1A1, EGFR, PTGS2, RELA, TYR |
3.73072 |
[BP] GO:0010511 |
None
|
HTR2A, HTR2B, HTR2C |
3.70074 |
[BP] GO:0006952 |
defense response
|
ADORA3, ALOX15, APP, AXL, BCL2, CNR2, DRD1, HTR1A, HTR2C, KIT, MIF, PIK3CA, PIK3CB, PTGES, PTGS1, PTGS2, RELA, SRC |
3.68746 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
BCL2, CNR1, EGFR, HTR2B, MET, PIK3CA, PPARA, RELA, SMAD3 |
3.68053 |
[BP] GO:2001023 |
None
|
CNR1, DRD1, DRD2, HTR1B, HTR2A, MET |
3.68053 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
AKR1C3, EGFR, INSR, PTGS2, SMAD3, XDH |
3.65457 |
[BP] GO:0050776 |
regulation of immune response
|
ALOX15, BCL2, CNR1, DRD2, DUSP3, ESR1, HSPA1A, KIT, MAP3K7, MIF, MMP12, MMP2, PIK3CA, PIK3CB, RELA, SMAD3, SRC |
3.6383 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.60302 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, DRD1, EGFR, HTR1B, IGF1R, INSR, MMP2, PTGS2, RELA, SRC |
3.59077 |
[BP] GO:0050890 |
None
|
APP, CNR1, DRD1, DRD2, EGFR, HTR2A, INSR, KIT, PTGS2 |
3.56886 |
[BP] GO:0032845 |
None
|
BCL2, DRD2, HTR2A, HTR2B, HTR2C, MIF, SRC |
3.56646 |
[BP] GO:0050900 |
leukocyte migration
|
CNR2, FUT7, KIT, MIF, MMP1, MMP9, PIK3CA, PIK3CB, SRC, TEK |
3.53612 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA3, ALOX15, APP, AR, AURKB, BCL2, CA9, CSNK2A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HSPA1A, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
3.53486 |
[BP] GO:0009410 |
None
|
CNR1, CNR2, DRD1, DRD2, EGFR, HTR1B, RELA |
3.53039 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MIF, MMP9, PTGS2, SRC |
3.52837 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA3, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CA12, CA2, CA4, CA7, CA9, CACNA1C, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GPR35, HSD17B1, HSD17B2, HSD17B3, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, RELA, SMAD3, SRC, TEK, TYR, XDH |
3.52656 |
[BP] GO:0044598 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.5206 |
[BP] GO:0044597 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.5206 |
[BP] GO:0030638 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.5206 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
CNR1, EGFR, F3, FABP4, KDR, MET, MIF, PTGS2, SMAD3 |
3.49231 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
AR, BCL2, HSPA1A, MIF, MMP9, PTGS2, RELA, SRC |
3.47214 |
[BP] GO:0046686 |
response to cadmium ion
|
AKR1C3, CYP1A2, EGFR, KIT, MMP9 |
3.47214 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
AR, BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
3.45935 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
AKR1C3, APP, AR, AURKB, BCL2, CNR1, CSNK2A1, DRD2, DUSP3, ESR1, ESR2, ESRRA, FABP4, HSPA1A, HTR1B, HTR1E, HTR2B, IGF1R, MET, MIF, MMP12, MMP9, PIK3CA, PPARA, PTGS2, RELA, SMAD3, SRC, XDH |
3.44428 |
[BP] GO:0051046 |
None
|
ACHE, CACNA1C, CNR1, CYP19A1, DRD2, EGFR, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, MIF, MMP12, SRC |
3.43958 |
[BP] GO:0033138 |
positive regulation of peptidyl-serine phosphorylation
|
APP, BCL2, EGFR, MIF, PIK3CA, PTGS2 |
3.43937 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
AR, BCL2, DRD2, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PTGS2, RELA, SMAD3, SRC, XDH |
3.43278 |
[BP] GO:0051480 |
regulation of cytosolic calcium ion concentration
|
CACNA1C, DRD1, DRD2, ESR1, GPR35, HTR2A, HTR2B, HTR2C, SMAD3 |
3.42865 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AKR1B10, AKR1C3, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, FUT7, HSPA1A, MAOA, MMP1, MMP12, MMP2, MMP9, PIK3CB, SRC, XDH |
3.42865 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, HTR2A, MET, SRC |
3.39695 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, HTR2A, MET, SRC |
3.39695 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, HTR2A, MET, SRC |
3.39695 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, HTR2A, MET, SRC |
3.39695 |
[BP] GO:0009653 |
anatomical structure morphogenesis
|
APP, AR, AXL, BCL2, CA2, CA9, CACNA1C, CYP1B1, DRD2, EGFR, ESR1, HTR2B, INSR, MET, MMP2, RELA, SMAD3, SRC, TEK |
3.37803 |
[BP] GO:0010517 |
regulation of phospholipase activity
|
EGFR, ESR1, HTR2A, HTR2B, KIT |
3.37507 |
[BP] GO:0090066 |
None
|
ALOX15, DRD1, EGFR, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
3.37507 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, APP, AXL, BCL2, CA2, CYP19A1, DRD1, DRD2, EGFR, HTR2B, INSR, MIF, MMP12, PTGS2, SMAD3, SRC |
3.37442 |
[BP] GO:0030647 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.36956 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, ESR1, HSD17B3 |
3.36416 |
[BP] GO:0014059 |
None
|
CNR1, DRD2, HTR1B, HTR2A |
3.36416 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, KDR, PIK3CB, SMAD3, SRC, TEK |
3.35763 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, APP, AR, AXL, CNR1, CYP1A1, DRD1, EGFR, ESR1, KIT, PTGS2, SRC |
3.3548 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA3, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CA9, CACNA1C, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GPR35, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
3.33444 |
[BP] GO:0048015 |
phosphatidylinositol-mediated signaling
|
HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB |
3.31593 |
[BP] GO:0007613 |
None
|
CNR1, DRD1, DRD2, HTR2A, INSR, PTGS2 |
3.31593 |
[BP] GO:0060193 |
positive regulation of lipase activity
|
EGFR, ESR1, HTR2A, HTR2B, KIT |
3.28246 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA3, APP, AXL, BCL2, CSNK2A1, DRD2, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, KIT, MAP3K7, MET, MIF, MMP2, MMP9, PIK3CA, PIK3CB, RELA, SMAD3, SRC, TEK |
3.27863 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, AKR1C3, ALOX15, CYP19A1, CYP3A4, HSD17B3, TYR |
3.27724 |
[BP] GO:0035265 |
organ growth
|
AR, BCL2, CYP19A1, ESR1 |
3.25714 |
[BP] GO:0002209 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
3.25714 |
[BP] GO:0001662 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
3.25714 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, KIT, SRC, TEK |
3.25714 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, RELA, SRC |
3.25714 |
[BP] GO:0008406 |
gonad development
|
AKR1C3, BCL2, CYP19A1, ESR1, INSR, KIT |
3.25714 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.23849 |
[BP] GO:0046889 |
None
|
FABP3, HTR2A, HTR2B, HTR2C, PTGS2 |
3.22905 |
[BP] GO:0060402 |
None
|
CACNA1C, DRD2, HTR2A, HTR2B, HTR2C |
3.22905 |
[BP] GO:0048017 |
inositol lipid-mediated signaling
|
HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB |
3.22905 |
[BP] GO:0030155 |
regulation of cell adhesion
|
ALOX15, BCL2, CYP1B1, DUSP3, KDR, MAP3K7, NUAK1, PIK3CA, PIK3CB, PPARA, SMAD3, SRC, TEK |
3.2209 |
[BP] GO:0071276 |
cellular response to cadmium ion
|
AKR1C3, CYP1A2, EGFR, MMP9 |
3.20884 |
[BP] GO:2000026 |
regulation of multicellular organismal development
|
APP, AR, AXL, BCL2, CA2, CNR1, CYP1B1, DRD2, EGFR, ESR1, ESRRA, F3, INSR, KDR, KIT, MAP2K1, PIM1, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
3.20884 |
[BP] GO:0048534 |
hematopoietic or lymphoid organ development
|
BCL2, FLT3, KDR, KIT, MAP2K1, TEK, TYR |
3.20884 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
3.20884 |
[BP] GO:1900542 |
None
|
DRD1, DRD2, ESRRB, HTR1B, HTR1E, HTR2A, INSR, PPARA |
3.19559 |
[BP] GO:0022029 |
None
|
DRD1, DRD2, EGFR, HTR6 |
3.15878 |
[BP] GO:0042596 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
3.15878 |
[BP] GO:0051282 |
None
|
CACNA1C, DRD1, DRD2, HTR2A, HTR2B, HTR2C |
3.15878 |
[BP] GO:0045597 |
positive regulation of cell differentiation
|
APP, AR, AXL, BCL2, CA2, CNR1, DRD2, HTR2A, HTR2C, KDR, KIT, MAP2K1, PTGS2, RELA, SMAD3 |
3.1551 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, AKR1C3, ALPL, APP, AR, AXL, BCL2, CYP1A1, DRD1, DRD2, EGFR, ESR1, ESRRB, FABP4, FLT3, FUT7, HTR2B, KDR, KIT, MAP2K1, MET, MIF, MMP2, MMP9, PTGS2, SMAD3, SRC, TEK |
3.1501 |
[BP] GO:0031348 |
negative regulation of defense response
|
CNR2, CYP19A1, DRD2, MMP12, PPARA, SMAD3, TEK |
3.1501 |
[BP] GO:0032147 |
activation of protein kinase activity
|
DRD2, EGFR, INSR, KIT, MAP2K1, MAP3K7, PIK3CA, PIK3CB, SRC |
3.14303 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, NQO2, PTGS1 |
3.1419 |
[BP] GO:0002031 |
None
|
DRD2, HTR1B, HTR2B |
3.12293 |
[BP] GO:0002320 |
lymphoid progenitor cell differentiation
|
BCL2, FLT3, KIT |
3.12293 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
3.12293 |
[BP] GO:0045913 |
None
|
ESRRB, HTR2A, INSR, PPARA, SRC |
3.11868 |
[BP] GO:0006140 |
None
|
DRD1, DRD2, ESRRB, HTR1B, HTR1E, HTR2A, INSR, PPARA |
3.11749 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
FLT3, KIT, SRC, TEK |
3.11749 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
3.11749 |
[BP] GO:0050679 |
None
|
AR, EGFR, F3, HTR2B, KDR, MMP12, TEK |
3.09599 |
[BP] GO:0051091 |
positive regulation of DNA binding transcription factor activity
|
APP, AR, ESR1, ESR2, HSPA1A, KIT, MAP3K7, RELA |
3.09599 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, AKR1C3, CYP19A1, HSD17B3 |
3.0954 |
[BP] GO:0009605 |
response to external stimulus
|
AKR1C3, ALPL, AXL, BCL2, CNR1, CNR2, CYP1A1, CYP1A2, EGFR, HSD11B2, HTR2A, KIT, MMP12, PTGES, PTGS2, RELA, SMAD3, SRC, TYR |
3.07599 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
AKR1B1, DRD1, DRD2, HTR2A, MET, PIK3CA |
3.07015 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CA9, CSNK2A1, EGFR, RELA, SRC |
3.05396 |
[BP] GO:0007204 |
positive regulation of cytosolic calcium ion concentration
|
CACNA1C, DRD1, DRD2, ESR1, GPR35, HTR2A, HTR2B, HTR2C |
3.04179 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA3, APP, AR, BCL2, CYP1B1, DRD2, FABP3, HSPA1A, MAP2K1, PTGES, PTGS2, SMAD3, XDH |
3.02859 |
[BP] GO:0090087 |
None
|
ACHE, APP, CA2, CACNA1C, CNR1, DRD2, EGFR, HTR2B, HTR2C, MIF, MMP12, PTGS2, SMAD3, SRC |
3.01879 |
[BP] GO:0045759 |
None
|
CNR1, CNR2, GPR35 |
3.01879 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, KDR, PIK3CA, PIK3CB, SRC |
3.01644 |
[BP] GO:0007208 |
None
|
HTR2A, HTR2C |
3.013 |
[BP] GO:0016488 |
None
|
AKR1B10, AKR1C3 |
3.013 |
[BP] GO:0016487 |
None
|
AKR1B10, AKR1C3 |
3.013 |
[BP] GO:0016107 |
None
|
AKR1B10, AKR1C3 |
3.013 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
3.013 |
[BP] GO:0006714 |
None
|
AKR1B10, AKR1C3 |
3.013 |
[BP] GO:0050678 |
None
|
AR, EGFR, F3, HTR2B, KDR, MMP12, SMAD3, TEK, XDH |
3.00777 |
[BP] GO:0031349 |
positive regulation of defense response
|
CNR1, EGFR, FABP4, HSPA1A, MAP3K7, MMP12, MMP2, PTGS2, RELA, SRC |
2.98631 |
[BP] GO:0071383 |
None
|
AKR1C3, AR, EGFR, FLT3, SRC |
2.97232 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, EGFR, ESR1, ESRRA, HTR5A, PTGS2 |
2.97213 |
[BP] GO:1904951 |
positive regulation of establishment of protein localization
|
ACHE, APP, BCL2, DRD2, EGFR, HTR2B, MIF, MMP12, PTGS2, SMAD3, SRC |
2.95557 |
[BP] GO:0009314 |
response to radiation
|
APP, AURKB, BCL2, DRD1, DRD2, EGFR, KIT, PTGS2, RELA, TYR |
2.95557 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC, TEK |
2.95509 |
[BP] GO:0006650 |
glycerophospholipid metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, EGFR, KIT, MET, PIK3CA, PIK3CB |
2.95353 |
[BP] GO:0010810 |
regulation of cell-substrate adhesion
|
ALOX15, BCL2, KDR, PIK3CB, SMAD3, SRC, TEK |
2.92909 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.92753 |
[BP] GO:0001817 |
regulation of cytokine production
|
AXL, CYP1B1, DRD2, HSPA1A, HTR2B, MAP3K7, MIF, MMP12, PTGS2, RELA, SMAD3, SRC |
2.92572 |
[BP] GO:0051952 |
None
|
CNR1, DRD1, DRD2, HTR1B, HTR2A |
2.92499 |
[BP] GO:0060401 |
None
|
CACNA1C, DRD2, HTR2A, HTR2B, HTR2C |
2.92499 |
[BP] GO:0048806 |
genitalia development
|
AXL, CYP19A1, ESR1, HSD17B3 |
2.90817 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, HTR1B, MMP2, MMP9, PTGS2 |
2.90402 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AR, AURKB, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, HTR2A, IGF1R, INSR, MAP2K1, MET, MMP12, PPARA, RELA, SMAD3, SRC |
2.90007 |
[BP] GO:0032870 |
cellular response to hormone stimulus
|
AKR1C3, AR, EGFR, ESR1, FLT3, INSR, KIT, RELA, SRC |
2.89141 |
[BP] GO:0046883 |
regulation of hormone secretion
|
CACNA1C, CNR1, CYP19A1, DRD2, EGFR, HTR1A, HTR2A, HTR2C |
2.89059 |
[BP] GO:0001775 |
cell activation
|
ALOX5, APP, AXL, BCL2, EGFR, FLT3, FUT7, HSPA1A, KIT, MIF, MMP9, PIK3CA, PIK3CB, SMAD3, SRC |
2.86267 |
[BP] GO:0033135 |
regulation of peptidyl-serine phosphorylation
|
APP, BCL2, EGFR, MIF, PIK3CA, PTGS2 |
2.85256 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.8358 |
[BP] GO:0051967 |
None
|
DRD2, HTR1B, HTR2A |
2.8358 |
[BP] GO:0009411 |
response to UV
|
AURKB, BCL2, EGFR, PTGS2, RELA, TYR |
2.81813 |
[BP] GO:0016042 |
lipid catabolic process
|
AKR1B10, AKR1C3, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
2.81567 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, MIF, PIM1, PPARA, PTGES, PTGS1, PTGS2, TYR |
2.79034 |
[BP] GO:1904407 |
positive regulation of nitric oxide metabolic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.79034 |
[BP] GO:0035094 |
response to nicotine
|
BCL2, CNR1, DRD2, RELA |
2.79034 |
[BP] GO:0045429 |
positive regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.79034 |
[BP] GO:0048729 |
tissue morphogenesis
|
AR, BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.78806 |
[BP] GO:0050673 |
epithelial cell proliferation
|
ESR1, KIT, MAP2K1, PIK3CB, TEK |
2.78261 |
[BP] GO:0007612 |
None
|
APP, DRD1, DRD2, INSR, KIT, PTGS2 |
2.77235 |
[BP] GO:1901224 |
None
|
APP, EGFR, MAP3K7, RELA |
2.75185 |
[BP] GO:1903798 |
None
|
EGFR, ESR1, MAP2K1 |
2.7516 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, DUSP3, EGFR, HSPA1A, IGF1R, MAP2K1, MAP3K7, MET, MIF, NUAK1, PTGS2, XDH |
2.74192 |
[BP] GO:0043434 |
None
|
FABP3, HSD11B2, INSR, PPARA, PTGS2, RELA, SRC, TEK |
2.73701 |
[BP] GO:0002791 |
None
|
ACHE, CACNA1C, CNR1, DRD2, EGFR, HTR2B, HTR2C, MIF, MMP12, SRC |
2.73198 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
CNR2, CYP19A1, DRD1, DRD2, MIF, PPARA, SMAD3, TEK |
2.7277 |
[BP] GO:0032868 |
None
|
FABP3, HSD11B2, INSR, PPARA, RELA, SRC |
2.72603 |
[BP] GO:0051384 |
response to glucocorticoid
|
ALPL, BCL2, EGFR, FLT3, HSD11B2, PTGS2 |
2.72603 |
[BP] GO:0040008 |
regulation of growth
|
APP, AR, BCL2, CSNK2A1, DRD2, EGFR, ESR2, HSPA1A, INSR, PIK3CA, PIM1, SMAD3 |
2.72196 |
[BP] GO:0051128 |
regulation of cellular component organization
|
ALOX15, APP, AR, AURKB, AXL, BCL2, CNR1, CSNK2A1, DRD2, EGFR, ESR1, ESR2, HSPA1A, IGF1R, INSR, KDR, KIT, MAP2K1, MET, MMP1, MMP9, PIK3CB, SMAD3, SRC, TEK |
2.72196 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC |
2.72196 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, MAOA |
2.72196 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, MAOA |
2.72196 |
[BP] GO:0043551 |
regulation of phosphatidylinositol 3-kinase activity
|
FLT3, KIT, SRC, TEK |
2.72196 |
[BP] GO:0060191 |
regulation of lipase activity
|
EGFR, ESR1, HTR2A, HTR2B, KIT |
2.7209 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, F3, MMP9, PTGS2, SMAD3, SRC, XDH |
2.71131 |
[BP] GO:0006633 |
None
|
ALOX15, MIF, PTGES, PTGS1, PTGS2 |
2.6997 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
AKR1C3, MMP1, MMP12, MMP2, MMP9 |
2.6997 |
[BP] GO:0050999 |
None
|
CNR1, CNR2, EGFR, HTR2B |
2.68708 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADORA3, AKR1B1, AKR1C3, ALOX15, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CA9, CACNA1C, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GPR35, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
2.68515 |
[BP] GO:2000811 |
negative regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.68292 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.68292 |
[BP] GO:0070920 |
None
|
EGFR, ESR1, MAP2K1 |
2.68292 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, PTGS2 |
2.68292 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX15, ALOX5, PTGS2 |
2.68292 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APP, AURKB, CYP1A1, DRD2, DUSP3, EGFR, INSR, MIF, SRC |
2.66574 |
[BP] GO:0019637 |
organophosphate metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, EGFR, HSPA1A, HTR2B, HTR2C, KIT, MET, PIK3CA, PIK3CB, PTGS2, XDH |
2.66286 |
[BP] GO:0060359 |
None
|
CNR1, DRD1, DRD2, HTR1B, RELA |
2.66162 |
[BP] GO:0051283 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.65878 |
[BP] GO:0051209 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.65878 |
[BP] GO:0006936 |
None
|
DRD1, DRD2, HTR1D, HTR2A, HTR2B, HTR7, PIK3CA |
2.62141 |
[BP] GO:0051588 |
None
|
DRD1, DRD2, HTR1A, HTR1B, HTR2C |
2.61804 |
[BP] GO:0023014 |
signal transduction by protein phosphorylation
|
EGFR, HTR2B, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, TEK |
2.61775 |
[BP] GO:0031329 |
regulation of cellular catabolic process
|
BCL2, CNR1, ESRRB, HSPA1A, HTR2A, HTR2B, INSR, KDR, MAP3K7, MET, PIK3CA, PIK3CB, PPARA |
2.61484 |
[BP] GO:0032872 |
regulation of stress-activated MAPK cascade
|
APP, DUSP3, EGFR, IGF1R, MAP2K1, MAP3K7, XDH |
2.61185 |
[BP] GO:0033590 |
None
|
EGFR, RELA |
2.60887 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.60887 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.60887 |
[BP] GO:0033602 |
None
|
CNR1, DRD2 |
2.60887 |
[BP] GO:0002520 |
None
|
CACNA1C, SMAD3 |
2.60887 |
[BP] GO:0016095 |
None
|
AKR1B10, AKR1C3 |
2.60887 |
[BP] GO:0070302 |
regulation of stress-activated protein kinase signaling cascade
|
APP, DUSP3, EGFR, IGF1R, MAP2K1, MAP3K7, XDH |
2.60887 |
[BP] GO:0072330 |
monocarboxylic acid biosynthetic process
|
ALOX15, CYP1A1, MIF, PTGES, PTGS1, PTGS2 |
2.60887 |
[BP] GO:0050433 |
None
|
CNR1, DRD2, HTR1B, HTR2A |
2.59873 |
[BP] GO:2001233 |
regulation of apoptotic signaling pathway
|
AR, BCL2, HSPA1A, MIF, MMP9, PTGS2, RELA, SMAD3, SRC |
2.59597 |
[BP] GO:0008584 |
None
|
AKR1C3, BCL2, ESR1, INSR, KIT |
2.58736 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, APP, AR, BCL2, CACNA1C, CNR1, CSNK2A1, DRD2, EGFR, HTR2B, MIF, MMP12, PTGS2, SMAD3, SRC |
2.57643 |
[BP] GO:0008542 |
None
|
APP, DRD1, DRD2, KIT |
2.56557 |
[BP] GO:0051222 |
positive regulation of protein transport
|
ACHE, APP, DRD2, EGFR, HTR2B, MIF, MMP12, PTGS2, SMAD3, SRC |
2.5493 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.54923 |
[BP] GO:0045821 |
None
|
ESRRB, HTR2A, INSR |
2.54923 |
[BP] GO:0045595 |
regulation of cell differentiation
|
APP, AR, AXL, BCL2, CA2, CNR1, DRD2, EGFR, ESRRA, ESRRB, HTR2A, HTR2C, KDR, KIT, MAP2K1, PPARA, PTGS2, RELA, SMAD3, XDH |
2.52978 |
[BP] GO:0007631 |
None
|
APP, DRD1, DRD2, HTR1B, HTR2C |
2.52777 |
[BP] GO:0051726 |
regulation of cell cycle
|
APP, AURKB, BCL2, CSNK2A1, CYP1A1, DRD2, DUSP3, EGFR, HSPA1A, INSR, MAP2K1, MIF, PIM1, PTGS2, SMAD3, SRC |
2.52007 |
[BP] GO:0044089 |
positive regulation of cellular component biogenesis
|
ALOX15, ESR1, HSPA1A, KDR, KIT, MET, MMP1, SMAD3, SRC, TEK |
2.51746 |
[BP] GO:0003014 |
None
|
AKR1B1, AKR1C3, BCL2, DRD2, HSD11B2 |
2.50839 |
[BP] GO:0043207 |
response to external biotic stimulus
|
ALPL, AXL, BCL2, CNR1, CNR2, CYP1A1, CYP1A2, MMP12, PTGES, PTGS2, RELA, SMAD3, SRC |
2.5004 |
[BP] GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling
|
EGFR, FLT3, KDR, KIT, TEK |
2.48925 |
[BP] GO:0016101 |
None
|
AKR1B10, AKR1C3, CYP1A1, CYP1B1, EGFR |
2.48925 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.4844 |
[BP] GO:0051197 |
None
|
ESRRB, HTR2A, INSR |
2.4844 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA3, ALOX15, APP, AR, AURKB, BCL2, CA9, CSNK2A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, HSPA1A, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
2.48389 |
[BP] GO:2001242 |
regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MIF, MMP9, PTGS2, SRC |
2.46841 |
[BP] GO:0051051 |
negative regulation of transport
|
APP, BCL2, CNR1, DRD2, GPR35, HSPA1A, HTR1B, HTR2A, MMP9, PTGS2 |
2.45216 |
[BP] GO:0046854 |
phosphatidylinositol phosphorylation
|
EGFR, KIT, MET, PIK3CA, PIK3CB |
2.45216 |
[BP] GO:0042391 |
None
|
APP, BCL2, CACNA1C, CNR1, CNR2, DRD1, GPR35, KDR, SRC |
2.45216 |
[BP] GO:0050730 |
None
|
APP, EGFR, FLT3, HTR2A, KIT, MIF, SRC |
2.44714 |
[BP] GO:0032989 |
cellular component morphogenesis
|
APP, AR, AXL, BCL2, DRD2, EGFR, MET, SRC, TEK |
2.44714 |
[BP] GO:1903428 |
positive regulation of reactive oxygen species biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.44714 |
[BP] GO:0010676 |
None
|
ESRRB, INSR, PPARA, SRC |
2.44714 |
[BP] GO:0043550 |
regulation of lipid kinase activity
|
FLT3, KIT, SRC, TEK |
2.44714 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
2.44499 |
[BP] GO:0051336 |
regulation of hydrolase activity
|
APP, CSNK2A1, DRD2, EGFR, ESR1, F3, HSPA1A, HTR2A, HTR2B, KIT, MMP9, NUAK1, PTGS2, SMAD3, SRC, XDH |
2.43944 |
[BP] GO:0000904 |
cell morphogenesis involved in differentiation
|
AR, AXL, MET, SRC, TEK |
2.43761 |
[BP] GO:0070201 |
None
|
ACHE, APP, BCL2, CACNA1C, CNR1, DRD2, EGFR, HTR2B, MIF, MMP12, PTGS2, SMAD3, SRC |
2.42855 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, HTR2A |
2.42641 |
[BP] GO:0098900 |
None
|
CACNA1C, CNR1, CNR2, GPR35 |
2.42044 |
[BP] GO:0007632 |
None
|
APP, DRD1, DRD2, KIT |
2.42044 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, NQO2, XDH |
2.42044 |
[BP] GO:0002683 |
negative regulation of immune system process
|
ALOX15, AXL, CNR1, CNR2, CYP19A1, DRD2, DUSP3, MIF, MMP12 |
2.41345 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
CACNA1C, DRD1, DRD2, EGFR, HTR2B, HTR5A, KDR |
2.41107 |
[BP] GO:0050714 |
None
|
ACHE, DRD2, EGFR, HTR2B, MIF, MMP12, SRC |
2.41107 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
AKR1C3, BCL2, CNR1, CYP1B1, F3, MMP9, PIK3CB, PTGS2, SMAD3, SRC, XDH |
2.40489 |
[BP] GO:0043436 |
oxoacid metabolic process
|
AKR1C3, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, MIF, PIM1, PPARA, PTGES, PTGS1, PTGS2, TYR |
2.40489 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.40489 |
[BP] GO:2000116 |
regulation of cysteine-type endopeptidase activity
|
CSNK2A1, F3, MMP9, PTGS2, SMAD3, SRC, XDH |
2.4025 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.39649 |
[BP] GO:0033555 |
multicellular organismal response to stress
|
BCL2, DRD1, HTR1A, HTR2C |
2.39649 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.39649 |
[BP] GO:0006644 |
phospholipid metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, EGFR, KIT, MET, PIK3CA, PIK3CB |
2.39649 |
[BP] GO:2001237 |
negative regulation of extrinsic apoptotic signaling pathway
|
AR, BCL2, HSPA1A, RELA, SRC |
2.38916 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
AKR1C3, BCL2, CNR1, CYP1B1, F3, MMP9, PIK3CB, PTGS2, SMAD3, SRC, XDH |
2.37463 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.37463 |
[BP] GO:0051968 |
None
|
DRD1, EGFR, PTGS2 |
2.37463 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.37463 |
[BP] GO:0031623 |
None
|
ACHE, DRD2, HTR1B, HTR2B |
2.37024 |
[BP] GO:0032768 |
None
|
CNR1, CNR2, EGFR, HTR2B |
2.37024 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, AURKB, BCL2, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
2.3655 |
[BP] GO:0046890 |
None
|
AKR1C3, FABP3, HTR2A, HTR2B, HTR2C, PTGS2 |
2.36232 |
[BP] GO:0001889 |
liver development
|
CSNK2A1, EGFR, PIK3CA, RELA, SMAD3 |
2.36032 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.36032 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.36032 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.36032 |
[BP] GO:0014827 |
None
|
HTR1D, HTR2B |
2.36032 |
[BP] GO:0009607 |
response to biotic stimulus
|
ALPL, AXL, BCL2, CNR1, CNR2, CYP1A1, CYP1A2, MMP12, PTGES, PTGS2, RELA, SMAD3, SRC |
2.35505 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
AKR1C3, MMP1, MMP12, MMP2, MMP9 |
2.34506 |
[BP] GO:0006082 |
organic acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, MIF, PIM1, PPARA, PTGES, PTGS1, PTGS2, TYR |
2.3442 |
[BP] GO:0030258 |
lipid modification
|
CYP1A1, CYP3A4, EGFR, KIT, MET, PIK3CA, PIK3CB |
2.3442 |
[BP] GO:0015711 |
organic anion transport
|
CA12, CA14, CA2, CA4, CA7, CA9, DRD2, FABP3, PPARA |
2.34344 |
[BP] GO:0044057 |
None
|
ADORA3, CACNA1C, DRD2, EGFR, GPR35, HTR2A, HTR2C, KIT, PTGS2, SMAD3 |
2.33051 |
[BP] GO:0002694 |
regulation of leukocyte activation
|
APP, AXL, BCL2, CNR1, CNR2, DUSP3, MAP3K7, MIF, PIK3CA, SRC |
2.33051 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
HTR1B, MMP2, MMP9 |
2.33051 |
[BP] GO:0051194 |
None
|
ESRRB, HTR2A, INSR |
2.33051 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.33051 |
[BP] GO:0071363 |
cellular response to growth factor stimulus
|
APP, EGFR, INSR, KDR, RELA, SMAD3, SRC |
2.32958 |
[BP] GO:0097553 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.32958 |
[BP] GO:0072347 |
None
|
CNR1, DRD2, HTR1B, RELA |
2.32958 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.32958 |
[BP] GO:0045428 |
regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.32958 |
[BP] GO:0050708 |
None
|
ACHE, CACNA1C, CNR1, DRD2, EGFR, HTR2B, MIF, MMP12, SRC |
2.30444 |
[BP] GO:2000209 |
regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.27668 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.27668 |
[BP] GO:1904018 |
positive regulation of vasculature development
|
CYP1B1, F3, KDR, KIT, PTGS2, TEK |
2.27334 |
[BP] GO:0035295 |
tube development
|
AKR1B1, AR, CYP1A1, EGFR, KIT, SMAD3 |
2.27334 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, APP, AR, AURKB, AXL, BCL2, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F3, FLT3, FUT7, HTR2B, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIM1, PPARA, RELA, SMAD3, SRC, TEK |
2.27318 |
[BP] GO:0046834 |
lipid phosphorylation
|
EGFR, KIT, MET, PIK3CA, PIK3CB |
2.26519 |
[BP] GO:0000165 |
MAPK cascade
|
EGFR, HTR2B, KDR, KIT, MAP2K1, MAP3K7, MET, TEK |
2.26144 |
[BP] GO:0050715 |
None
|
DRD2, HTR2B, MIF, MMP12, SRC |
2.24826 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AR, AURKB, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, IGF1R, INSR, KDR, MAP2K1, MET, MMP12, PPARA, RELA, SMAD3, SRC |
2.23734 |
[BP] GO:0002793 |
None
|
ACHE, DRD2, EGFR, HTR2B, MIF, MMP12, SRC |
2.23006 |
[BP] GO:0051704 |
multi-organism process
|
APP, AXL, BCL2, CYP1A1, EGFR, HSD11B2, HSPA1A, HTR2A, INSR, KDR, MAP2K1, MET, MMP1, MMP12, RELA, SMAD3, SRC |
2.2288 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.2288 |
[BP] GO:0007202 |
None
|
EGFR, HTR2A, HTR2B |
2.2288 |
[BP] GO:0032098 |
None
|
HTR2C, HTR4, PPARA |
2.2288 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.2288 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, AXL, CYP1B1, RELA |
2.22608 |
[BP] GO:0001525 |
angiogenesis
|
CYP1B1, KDR, MMP2, PIK3CA, PIK3CB, PTGS2, TEK |
2.22426 |
[BP] GO:0033554 |
cellular response to stress
|
AKR1B1, AKR1C3, ALOX15, AXL, BCL2, CA2, CA9, CYP1B1, EGFR, HSPA1A, MAP2K1, MAP3K7, MIF, MMP9, NUAK1, PTGS2, RELA, SRC |
2.22197 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SMAD3, SRC |
2.21715 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
CNR2, CYP19A1, PPARA, SMAD3, TEK |
2.20245 |
[BP] GO:1901222 |
None
|
APP, EGFR, MAP3K7, RELA |
2.20192 |
[BP] GO:0050920 |
regulation of chemotaxis
|
CYP19A1, F3, KDR, MET, MIF, SMAD3 |
2.19275 |
[BP] GO:0007423 |
None
|
BCL2, CACNA1C, CYP1A1, EGFR, KIT |
2.18684 |
[BP] GO:0050927 |
None
|
F3, KDR, SMAD3 |
2.18128 |
[BP] GO:0048169 |
None
|
APP, DRD2, KIT |
2.18128 |
[BP] GO:0002684 |
positive regulation of immune system process
|
APP, AXL, BCL2, CA2, CNR1, HSPA1A, MAP3K7, MIF, MMP12, MMP2, PIK3CA, PIK3CB, RELA, SRC |
2.17577 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.17577 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.17577 |
[BP] GO:0071502 |
None
|
HTR1B, HTR2B |
2.17577 |
[BP] GO:0002318 |
myeloid progenitor cell differentiation
|
FLT3, KIT |
2.17577 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.17577 |
[BP] GO:0009896 |
positive regulation of catabolic process
|
CSNK2A1, ESRRB, HSPA1A, HTR2A, INSR, KDR, MAP3K7, PIK3CB, PPARA |
2.17214 |
[BP] GO:0003012 |
None
|
DRD1, DRD2, HTR1D, HTR2A, HTR2B, HTR7, PIK3CA |
2.15609 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APP, AURKB, BCL2, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, MAP2K1, PIM1, SMAD3 |
2.15052 |
[BP] GO:0010942 |
positive regulation of cell death
|
AKR1C3, BCL2, CNR1, CYP1B1, F3, MMP9, PIK3CB, PTGS2, SMAD3, SRC, XDH |
2.14293 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.14293 |
[BP] GO:0050926 |
None
|
F3, KDR, SMAD3 |
2.14293 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.14293 |
[BP] GO:0001975 |
None
|
CNR2, DRD1, DRD2 |
2.14293 |
[BP] GO:0046394 |
None
|
ALOX15, ALOX5, CYP1A1, MIF, PTGES, PTGS1, PTGS2 |
2.1418 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.14095 |
[BP] GO:0051926 |
negative regulation of calcium ion transport
|
BCL2, DRD2, GPR35, PTGS2 |
2.14095 |
[BP] GO:0006081 |
None
|
AKR1B10, AKR1C3, CYP1B1, RELA |
2.14095 |
[BP] GO:0009889 |
regulation of biosynthetic process
|
ADORA3, AKR1C3, APP, AR, AURKB, BCL2, CA9, CSNK2A1, CYP1B1, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HSPA1A, HTR1B, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, MMP12, PIM1, PPARA, PTGS2, RELA, SMAD3, SRC |
2.13903 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, AXL, CYP1B1, KDR, RELA |
2.13672 |
[BP] GO:0016053 |
None
|
ALOX15, ALOX5, CYP1A1, MIF, PTGES, PTGS1, PTGS2 |
2.13563 |
[BP] GO:1903532 |
None
|
ACHE, CYP19A1, DRD2, EGFR, HTR2B, MIF, MMP12, SRC |
2.13063 |
[BP] GO:0071396 |
cellular response to lipid
|
AKR1C3, AR, AXL, EGFR, ESR1, FLT3, RELA, SRC |
2.13063 |
[BP] GO:0050865 |
regulation of cell activation
|
APP, AXL, BCL2, CNR1, CNR2, DUSP3, MAP3K7, MIF, PIK3CA, SRC |
2.12345 |
[BP] GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling
|
FLT3, KDR, KIT, TEK |
2.11968 |
[BP] GO:0051223 |
None
|
ACHE, APP, CACNA1C, CNR1, DRD2, EGFR, HTR2B, MIF, MMP12, PTGS2, SMAD3, SRC |
2.11432 |
[BP] GO:0043467 |
regulation of generation of precursor metabolites and energy
|
ESRRB, HTR2A, INSR, PIK3CA, PPARA |
2.1077 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
APP, BCL2, DRD2, PIK3CA |
2.09756 |
[BP] GO:0006110 |
None
|
ESRRB, HTR2A, INSR, PPARA |
2.09756 |
[BP] GO:0009612 |
None
|
EGFR, HTR2A, KIT, PTGS2, RELA, SRC |
2.05971 |
[BP] GO:0051482 |
None
|
DRD1, GPR35, HTR2C |
2.05971 |
[BP] GO:0046320 |
None
|
CNR1, FABP3, PPARA |
2.05971 |
[BP] GO:0033032 |
regulation of myeloid cell apoptotic process
|
BCL2, MIF, PIK3CB |
2.05971 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, MAOA |
2.05971 |
[BP] GO:0070371 |
None
|
HTR2B, KDR, MAP2K1 |
2.05971 |
[BP] GO:0070848 |
response to growth factor
|
APP, EGFR, INSR, KDR, RELA, SMAD3, SRC |
2.03124 |
[BP] GO:0007416 |
None
|
ACHE, APP, DRD1, DRD2 |
2.03124 |
[BP] GO:0010760 |
negative regulation of macrophage chemotaxis
|
CYP19A1, MIF |
2.03124 |
[BP] GO:0021843 |
None
|
DRD1, DRD2 |
2.03124 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.03124 |
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.03124 |
[BP] GO:1990535 |
None
|
APP, INSR |
2.03124 |
[BP] GO:0021830 |
None
|
DRD1, DRD2 |
2.03124 |
[BP] GO:0014831 |
None
|
HTR1D, HTR2B |
2.03124 |
[BP] GO:0032229 |
None
|
CNR2, HTR1B |
2.03124 |
[BP] GO:0002933 |
lipid hydroxylation
|
CYP1A1, CYP3A4 |
2.03124 |
[BP] GO:0021826 |
None
|
DRD1, DRD2 |
2.03124 |
[BP] GO:2001300 |
lipoxin metabolic process
|
ALOX15, ALOX5 |
2.03124 |
[BP] GO:0016115 |
None
|
AKR1B10, AKR1C3 |
2.03124 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP3A4 |
2.03124 |
[BP] GO:0042181 |
None
|
AKR1C3, CYP19A1, HSD17B3 |
2.02517 |
[BP] GO:0033280 |
response to vitamin D
|
ALPL, PTGS2, TYR |
2.02517 |
[BP] GO:1900543 |
None
|
DRD2, HTR1B, HTR1E, PPARA |
2.01933 |
[BP] GO:0008306 |
None
|
APP, DRD1, DRD2, KIT |
2.01933 |
[BP] GO:0010507 |
negative regulation of autophagy
|
BCL2, HTR2B, MET, PIK3CA |
2.01933 |
[BP] GO:1900182 |
positive regulation of protein localization to nucleus
|
APP, EGFR, PTGS2, SMAD3, SRC |
2.00236 |
[BP] GO:0046683 |
response to organophosphorus
|
APP, PTGS2, RELA, TEK, TYR |
2.00236 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA3, APP, AXL, CA4, CNR1, CNR2, DRD1, DRD2, F3, FLT3, GPR35, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, TEK |
7.3168 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA3, ALOX15, ALPL, APP, AR, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CNR1, CNR2, CSNK2A1, DRD1, DRD2, EGFR, ESR1, F3, FLT3, GPR35, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, MMP2, PIK3CA, PIK3CB, PIM1, SMAD3, SRC, TEK |
7.28337 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA3, ALOX15, APP, AXL, CA2, CA4, CA9, CACNA1C, CNR1, CNR2, DRD1, DRD2, DUSP3, EGFR, F3, FLT3, GPR35, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, KIT, MET, PTGS2, SRC, TEK |
7.0345 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA3, ALOX15, ALOX5, ALPL, APP, AR, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, ESR1, F3, FLT3, FUT7, GPR35, HSD11B1, HSD11B2, HSD17B2, HSD17B3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTGES, PTGS1, PTGS2, SMAD3, SRC, TEK, TYR |
7.00579 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA3, APP, AXL, CNR1, CNR2, DRD1, DRD2, FLT3, GPR35, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, TEK |
6.43045 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA3, ALOX15, ALPL, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FLT3, FUT7, GPR35, HSD11B1, HSD11B2, HSD17B2, HSD17B3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, KIT, MAOA, MET, PIK3CA, PIK3CB, PTGES, PTGS1, PTGS2, SRC, TEK, TYR |
6.27296 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP, PTGES |
3.5206 |
[CC] GO:0045121 |
membrane raft
|
APP, CNR1, EGFR, HTR2A, INSR, KDR, PTGS2, SRC, TEK |
3.34884 |
[CC] GO:0098857 |
membrane microdomain
|
APP, CNR1, EGFR, HTR2A, INSR, KDR, PTGS2, SRC, TEK |
3.32728 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, EGFR, HSD11B1, HSD11B2, HSD17B2, HSD17B3, PTGES, PTGS1, PTGS2 |
3.04572 |
[CC] GO:0031224 |
None
|
ACHE, ADORA3, ALPL, APP, AXL, CA12, CA14, CA4, CA9, CACNA1C, CNR1, CNR2, CYP3A4, DRD1, DRD2, EGFR, ESR1, F3, FLT3, FUT7, GPR35, HSD11B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, KIT, MAOA, MET, PTGES, TEK, TYR |
3.04332 |
[CC] GO:0098589 |
membrane region
|
APP, CNR1, EGFR, HTR2A, INSR, KDR, PTGS2, SRC, TEK |
2.79326 |
[CC] GO:0016021 |
None
|
ADORA3, ALPL, APP, AXL, CA12, CA14, CA9, CACNA1C, CNR1, CNR2, CYP3A4, DRD1, DRD2, EGFR, ESR1, F3, FLT3, FUT7, GPR35, HSD11B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, KIT, MAOA, MET, PTGES, TEK, TYR |
2.66823 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, APP, AR, AURKB, BCL2, CA2, CA4, CA7, CACNA1C, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, HSPA1A, HTR2A, HTR4, HTR5A, INSR, KDR, KIT, MAOA, MAP2K1, MAP3K7, MIF, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PTGES, PTGS1, PTGS2, RELA, SMAD3, SRC, TYR, XDH |
2.55024 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, EGFR, FLT3, HSD11B1, HSD11B2, HSD17B2, HSD17B3, PTGES, PTGS1, PTGS2 |
2.53997 |
[CC] GO:0044464 |
cell part
|
ACHE, ADORA3, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GPR35, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, RELA, SMAD3, SRC, TEK, TYR, XDH |
2.02157 |
[CC] GO:0005901 |
caveola
|
HTR2A, INSR, PTGS2, SRC |
2.01933 |
[MF] GO:0004993 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
16.044 |
[MF] GO:0099589 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
16.044 |
[MF] GO:0043176 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
16.0375 |
[MF] GO:0051378 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
16.0375 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, RELA, SMAD3, SRC, TEK, TYR, XDH |
15.7182 |
[MF] GO:0099528 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
13.9021 |
[MF] GO:0008227 |
None
|
DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
13.6201 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA3, AR, AXL, CNR1, CNR2, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, KIT, MET, PPARA, TEK |
12.359 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
12.3163 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA3, AR, AXL, CNR1, CNR2, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, PPARA, SMAD3, TEK |
12.1508 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, AOX1, APP, AR, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, PPARA, SMAD3, TYR, XDH |
11.7979 |
[MF] GO:0030594 |
None
|
DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
11.7375 |
[MF] GO:0004872 |
receptor activity
|
ADORA3, AR, AXL, CNR1, CNR2, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, KIT, MET, PPARA, TEK |
10.9847 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
10.714 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA3, AR, AXL, CNR1, CNR2, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, KIT, MET, PPARA, TEK |
10.6372 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, FLT3, HSPA1A, HTR1B, HTR2A, HTR2B, HTR2C, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, SRC, TEK |
10.5369 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, MAOA, NQO2, PTGS1, PTGS2, TYR, XDH |
9.25898 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, KIT, MAP3K7, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIM1, PPARA, PTGS1, PTGS2, SMAD3, TYR, XDH |
9.17286 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA3, AXL, CNR1, CNR2, DRD1, DRD2, EGFR, F3, FLT3, GPR35, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, KIT, MET, TEK |
8.65989 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA3, AXL, CNR1, CNR2, DRD1, DRD2, EGFR, F3, FLT3, GPR35, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, KIT, MET, TEK |
8.65989 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, TEK |
8.48918 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, F3, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PTGES, PTGS1, PTGS2, SRC, TEK, TYR, XDH |
8.15485 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
7.99492 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, TEK |
7.64939 |
[MF] GO:0005496 |
steroid binding
|
AR, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, SHBG |
7.36326 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AKR1C3, AOX1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, XDH |
6.9504 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MAP2K1, MET, SRC, TEK |
6.94179 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1C3, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
6.49694 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
AKR1C3, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
6.32528 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, EGFR, HSD17B1, IGF1R, INSR, NQO2, SHBG |
6.16472 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, NUAK1, PIK3CA, PIM1, SRC, TEK |
6.09742 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK |
5.76972 |
[MF] GO:0097159 |
organic cyclic compound binding
|
AOX1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD11B2, HSD17B1, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, MMP12, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, RELA, SHBG, SMAD3, SRC, TEK, XDH |
5.51205 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, PTGS1, PTGS2, TYR |
5.38032 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B2, HSD17B1, NQO2, PTGES, PTGS1, PTGS2, SRC, XDH |
5.35927 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR, KIT |
5.28143 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, XDH |
5.2793 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.23853 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK |
5.23395 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, AKR1C3, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
5.13974 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
5.04809 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
5.04809 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
4.99162 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, PTGS1, PTGS2, SRC |
4.92464 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, INSR, PIK3CA, PIK3CB |
4.92434 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NQO2, PPARA, SMAD3 |
4.87962 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
4.7784 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, PTGS1, PTGS2, SRC |
4.69639 |
[MF] GO:0004497 |
monooxygenase activity
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
4.64439 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
4.62449 |
[MF] GO:0004930 |
None
|
ADORA3, CNR1, CNR2, DRD1, DRD2, GPR35, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
4.49729 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AR, AXL, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA, SHBG |
4.48039 |
[MF] GO:1901363 |
heterocyclic compound binding
|
AOX1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD11B2, HSD17B1, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, MMP12, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, RELA, SMAD3, SRC, TEK, XDH |
4.465 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK |
4.30596 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, APP, BCL2, CSNK2A1, DRD2, EGFR, ESR1, ESR2, FLT3, IGF1R, KDR, KIT, MAP3K7, MET, MIF, MMP9, NQO2, PTGS2, RELA, SMAD3, TYR, XDH |
4.2204 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
4.07932 |
[MF] GO:0005057 |
signal transducer activity, downstream of receptor
|
EGFR, INSR, KDR, KIT, MAP2K1, MAP3K7, SMAD3 |
4.00587 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AKR1C3, AOX1, XDH |
3.94733 |
[MF] GO:0047035 |
testosterone dehydrogenase (NAD+) activity
|
AKR1C3, HSD17B2, HSD17B3 |
3.92114 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
3.90287 |
[MF] GO:0043168 |
anion binding
|
ALOX15, AOX1, APP, AURKB, AXL, CSNK2A1, EGFR, F3, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PTGES, RELA, SRC, TEK, XDH |
3.6575 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, KIT, MAP3K7, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIM1, PPARA, PTGS1, PTGS2, SMAD3, TYR, XDH |
3.47214 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.36956 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, CSNK2A1, EGFR, ESRRB, FLT3, HTR2A, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, RELA, SMAD3, SRC |
3.25715 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, NQO2, XDH |
3.25714 |
[MF] GO:0046934 |
phosphatidylinositol-4,5-bisphosphate 3-kinase activity
|
EGFR, KIT, MET, PIK3CA, PIK3CB |
3.17038 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, EGFR, ESRRB, FLT3, HTR2A, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, RELA, SMAD3, SRC |
3.11749 |
[MF] GO:0052813 |
phosphatidylinositol bisphosphate kinase activity
|
EGFR, KIT, MET, PIK3CA, PIK3CB |
3.0954 |
[MF] GO:0000166 |
nucleotide binding
|
AOX1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, XDH |
3.04332 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
AOX1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, XDH |
3.04179 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
3.013 |
[MF] GO:0045550 |
None
|
AKR1B10, AKR1C3 |
3.013 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
3.013 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
3.013 |
[MF] GO:0071886 |
None
|
HTR2A, HTR2C |
3.013 |
[MF] GO:0035004 |
phosphatidylinositol 3-kinase activity
|
EGFR, KIT, MET, PIK3CA, PIK3CB |
2.97232 |
[MF] GO:0036094 |
small molecule binding
|
AOX1, AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, XDH |
2.86267 |
[MF] GO:0005524 |
ATP binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK |
2.81567 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK |
2.6997 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MAP2K1, MAP3K7, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK |
2.66823 |
[MF] GO:0050473 |
arachidonate 15-lipoxygenase activity
|
ALOX15, PTGS2 |
2.60887 |
[MF] GO:0047718 |
None
|
AKR1B10, AKR1C3 |
2.60887 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.60887 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.60887 |
[MF] GO:0047045 |
None
|
AKR1C3, HSD17B3 |
2.60887 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.36032 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.36032 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.36032 |
[MF] GO:0051425 |
None
|
APP, INSR |
2.36032 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.36032 |
[MF] GO:0019899 |
enzyme binding
|
APP, AR, AURKB, BCL2, CYP1A1, CYP1A2, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRB, F3, HSPA1A, KIT, MET, MIF, PPARA, PTGS2, RELA, SMAD3, SRC, TEK |
2.34873 |
[MF] GO:0003674 |
molecular_function
|
ACHE, ADORA3, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GPR35, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, HSPA1A, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, RELA, SHBG, SMAD3, SRC, TEK, TYR, XDH |
2.3442 |
[MF] GO:0005518 |
collagen binding
|
ACHE, MMP12, MMP9, SMAD3 |
2.17821 |
[MF] GO:0016829 |
lyase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
2.17577 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.17577 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.17577 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.17577 |
[MF] GO:0004033 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.14293 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX15, ALOX5, PTGS2 |
2.14293 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX15, ALOX5, PTGS2 |
2.10196 |
[MF] GO:0042803 |
protein homodimerization activity
|
ACHE, AOX1, BCL2, DRD2, FLT3, KIT, NQO2, PTGS2, RELA, SMAD3, TYR, XDH |
2.06218 |
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.03124 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
AXL, IGF1R, INSR |
2.02517 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.00236 |